SUBPHENOTYPIC CLASSIFICATION OF COVID-19 SURVIVORS AND RESPONSE TO TELEREHABILITATION: A LATENT CLASS ANALYSIS

被引:0
作者
Wang, Yide [1 ]
Xue, Qianqian [1 ]
Li, Zheng [1 ,2 ]
Li, Fengsen [1 ,2 ]
机构
[1] Xinjiang Med Univ, Dept Integrated Pulmonol, Clin Med Coll 4, 116 Huanghe Rd, Urumqi 830000, Xinjiang, Peoples R China
[2] Xinjiang Med Univ, Xinjiang Natl Clin Res Base Tradit Chinese Med, Urumqi, Xinjiang, Peoples R China
关键词
COVID-19; survivors; telerehabilitation; latent class analysis; subphenotypes; IDENTIFICATION; PHENOTYPES; NUMBER;
D O I
10.2340/jrm.v57.42726
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: Investigating the role of telerehabilitation in aiding recovery and societal reintegration for COVID-19 survivors, this study aims to identify distinct subphenotypes among survivors and assess their responsiveness to telerehabilitation. Design: A secondary analysis of a multicentre, April 2020 through to follow-up in 2021. Subjects/Patients: The study included 377 COVID19 survivors (47.1% male), with a mean age of 56.4 years. Methods: Data from the Telerehabilitation Programme for COVID-19 (TERECO) were analysed using Latent Class Analysis to identify subphenotypes based on baseline characteristics. Clinical outcomes were compared between subphenotypes and treatment groups. Results: Latent Class Analysis identified 2 phenotypes: Phenotype 1 (52.9%) characterized by impaired lung function and Phenotype 2 (47.1%) with better lung function. Among those receiving corticosteroids, only Phenotype 1 showed significant benefits from the TERECO intervention. Discrimination accuracy using forced expiratory volume in 1 s (FEV1) and peak expiratory flow was high Conclusion: Two distinct phenotypes were identified in COVID-19 survivors, suggesting potential improvements in clinical trial design and personalized treatment strategies based on initial pulmonary function. This insight can guide more targeted rehabilitation approaches, enhancing recovery outcomes for specific survivor groups.
引用
收藏
页数:10
相关论文
共 33 条
  • [1] [Anonymous], **DATA OBJECT**, DOI 10.5061/dryad.59zw3r27n
  • [2] Clinical phenotypes of critically ill COVID-19 patients
    Azoulay, Elie
    Zafrani, Lara
    Mirouse, Adrien
    Lengline, Etienne
    Darmon, Michael
    Chevret, Sylvie
    [J]. INTENSIVE CARE MEDICINE, 2020, 46 (08) : 1651 - 1652
  • [3] Nomograms in oncology: more than meets the eye
    Balachandran, Vinod P.
    Gonen, Mithat
    Smith, J. Joshua
    DeMatteo, Ronald P.
    [J]. LANCET ONCOLOGY, 2015, 16 (04) : E173 - E180
  • [4] Longitudinal respiratory subphenotypes in patients with COVID-19-related acute respiratory distress syndrome: results from three observational cohorts
    Bos, Lieuwe D. J.
    Sjoding, Michael
    Sinha, Pratik
    Bhavani, Sivasubramanium, V
    Lyons, Patrick G.
    Bewley, Alice F.
    Botta, Michela
    Tsonas, Anissa M.
    Neto, Ary Serpa
    Schultz, Marcus J.
    Dickson, Robert P.
    Paulus, Frederique
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (12) : 1377 - 1386
  • [5] Dahmer MK, 2022, LANCET RESP MED, V10, P289, DOI [10.1016/S2213-2600(21)00382, 10.1016/S2213-2600(21)00382-9]
  • [6] Latent class analysis of imaging and clinical respiratory parameters from patients with COVID-19-related ARDS identifies recruitment subphenotypes
    Filippini, Daan F. L.
    Di Gennaro, Elisa
    van Amstel, Rombout B. E.
    Beenen, Ludo F. M.
    Grasso, Salvatore
    Pisani, Luigi
    Bos, Lieuwe D. J.
    Smit, Marry R.
    [J]. CRITICAL CARE, 2022, 26 (01)
  • [7] Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
    Gutierrez-Gutierrez, Belen
    Dolores del Toro, Maria
    Borobia, Alberto M.
    Carcas, Antonio
    Jarrin, Inmaculada
    Yllescas, Maria
    Ryan, Pablo
    Pachon, Jeronimo
    Carratala, Jordi
    Berenguer, Juan
    Arribas, Jose Ramon
    Rodriguez-Bano, Jesus
    [J]. LANCET INFECTIOUS DISEASES, 2021, 21 (06) : 783 - 792
  • [8] In persistent dyspnea after COVID-19 ARDS, exercise training rehabilitation vs. usual PT reduced dyspnea at 90 d
    Hill, Nicholas S.
    [J]. ANNALS OF INTERNAL MEDICINE, 2023, 176 (10) : JC117 - JC117
  • [9] Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
    Horby, Peter W.
    Emberson, Jonathan R.
    Basnyat, Buddha
    Campbell, Mark
    Peto, Leon
    Pessoa-Amorim, Guilherme
    Staplin, Natalie
    Hamers, Raph L.
    Amuasi, John
    Nel, Jeremy
    Kestelyn, Evelyne
    Rawal, Manisha
    Jha, Roshan Kumar
    Phong, Nguyen Thanh
    Sumardi, Uun
    Paudel, Damodar
    Thach, Pham Ngoc
    Nasronudin, Nasronudin
    Stratton, Emma
    Mew, Louise
    Sarkar, Rahuldeb
    Baillie, J. Kenneth
    Buch, Maya H.
    Day, Jeremy
    Faust, Saul N.
    Jaki, Thomas
    Jeffery, Katie
    Juszczak, Edmund
    Knight, Marian
    Lim, Wei Shen
    Mafham, Marion
    Montgomery, Alan
    Mumford, Andrew
    Rowan, Kathryn
    Thwaites, Guy
    Haynes, Richard
    Landray, Martin J.
    [J]. LANCET, 2023, 401 (10387) : 1499 - 1507
  • [10] A systematic review of using population-level human mobility data to understand SARS-CoV-2 transmission
    Kostandova, Natalya
    Schluth, Catherine
    Arambepola, Rohan
    Atuhaire, Fatumah
    Berube, Sophie
    Chin, Taylor
    Cleary, Eimear
    Cortes-Azuero, Oscar
    Garcia-Carreras, Bernardo
    Grantz, Kyra H.
    Hitchings, Matt D. T.
    Huang, Angkana T.
    Kishore, Nishant
    Lai, Shengjie
    Larsen, Sophie L.
    Loisate, Stacie
    Martinez, Pamela
    Meredith, Hannah R.
    Purbey, Ritika
    Ramiadantsoa, Tanjona
    Read, Jonathan
    Rice, Benjamin L.
    Rosman, Lori
    Ruktanonchai, Nick
    Salje, Henrik
    Schaber, Kathryn L.
    Tatem, Andrew J.
    Wang, Jasmine
    Cummings, Derek A. T.
    Wesolowski, Amy
    [J]. NATURE COMMUNICATIONS, 2024, 15 (01)